$GKOS
GLAUKOS Corp

2024 Q4 Form 10-Q Financial Statement

#000155837024014295 Filed on November 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $96.67M
YoY Change 23.86%
Cost Of Revenue $22.58M
YoY Change 22.01%
Gross Profit $74.09M
YoY Change 24.43%
Gross Profit Margin 76.64%
Selling, General & Admin $64.00M
YoY Change 17.98%
% of Gross Profit 86.39%
Research & Development $34.75M
YoY Change 4.34%
% of Gross Profit 46.9%
Depreciation & Amortization $8.999M
YoY Change 6.5%
% of Gross Profit 12.15%
Operating Expenses $98.75M
YoY Change 12.79%
Operating Profit -$24.66M
YoY Change -11.96%
Interest Expense $1.037M
YoY Change -69.48%
% of Operating Profit
Other Income/Expense, Net $3.428M
YoY Change -243.01%
Pretax Income -$21.23M
YoY Change -30.17%
Income Tax $200.0K
% Of Pretax Income
Net Earnings -$21.41M
YoY Change -29.68%
Net Earnings / Revenue -22.15%
Basic Earnings Per Share -$0.39
Diluted Earnings Per Share -$0.39
COMMON SHARES
Basic Shares Outstanding 55.14M 54.95M
Diluted Shares Outstanding 55.04M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $262.5M
YoY Change -12.77%
Cash & Equivalents $100.1M
Short-Term Investments $162.3M
Other Short-Term Assets $18.51M
YoY Change -5.58%
Inventory $59.90M
Prepaid Expenses
Receivables $56.41M
Other Receivables $0.00
Total Short-Term Assets $397.3M
YoY Change -0.56%
LONG-TERM ASSETS
Property, Plant & Equipment $98.58M
YoY Change -4.36%
Goodwill $66.13M
YoY Change 0.0%
Intangibles $269.4M
YoY Change -6.84%
Long-Term Investments
YoY Change
Other Assets $25.44M
YoY Change 36.05%
Total Long-Term Assets $529.3M
YoY Change -3.61%
TOTAL ASSETS
Total Short-Term Assets $397.3M
Total Long-Term Assets $529.3M
Total Assets $926.5M
YoY Change -2.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.10M
YoY Change 6.63%
Accrued Expenses $60.58M
YoY Change 6.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $71.68M
YoY Change 6.76%
LONG-TERM LIABILITIES
Long-Term Debt $126.5M
YoY Change -64.19%
Other Long-Term Liabilities $22.08M
YoY Change 72.59%
Total Long-Term Liabilities $22.08M
YoY Change 72.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $71.68M
Total Long-Term Liabilities $22.08M
Total Liabilities $258.0M
YoY Change -45.21%
SHAREHOLDERS EQUITY
Retained Earnings -$711.9M
YoY Change 26.6%
Common Stock $1.378B
YoY Change 32.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $668.5M
YoY Change
Total Liabilities & Shareholders Equity $926.5M
YoY Change -2.33%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$21.41M
YoY Change -29.68%
Depreciation, Depletion And Amortization $8.999M
YoY Change 6.5%
Cash From Operating Activities -$9.586M
YoY Change 17.48%
INVESTING ACTIVITIES
Capital Expenditures $1.450M
YoY Change -56.85%
Acquisitions
YoY Change
Other Investing Activities $32.01M
YoY Change 75.32%
Cash From Investing Activities $30.56M
YoY Change 105.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.668M
YoY Change 29.42%
NET CHANGE
Cash From Operating Activities -9.586M
Cash From Investing Activities 30.56M
Cash From Financing Activities 9.668M
Net Change In Cash 30.64M
YoY Change 115.66%
FREE CASH FLOW
Cash From Operating Activities -$9.586M
Capital Expenditures $1.450M
Free Cash Flow -$11.04M
YoY Change -4.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000
dei Entity Registrant Name
EntityRegistrantName
GLAUKOS Corp
dei Entity Central Index Key
EntityCentralIndexKey
0001192448
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37463
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0945406
dei Entity Address Address Line1
EntityAddressAddressLine1
One Glaukos Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Aliso Viejo
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92656
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
367-9600
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
GKOS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55137429
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100143000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93467000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
162330000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
201964000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
56408000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39850000
CY2024Q3 us-gaap Inventory Net
InventoryNet
59895000
CY2023Q4 us-gaap Inventory Net
InventoryNet
41986000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18506000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18194000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
397282000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
395461000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4733000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5856000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
98581000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
103212000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27321000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27146000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
42365000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
44180000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
269418000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
282956000
CY2024Q3 us-gaap Goodwill
Goodwill
66134000
CY2023Q4 us-gaap Goodwill
Goodwill
66134000
CY2024Q3 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
20709000
CY2023Q4 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
15469000
CY2024Q3 us-gaap Assets
Assets
926543000
CY2023Q4 us-gaap Assets
Assets
940414000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11103000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13440000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60581000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60574000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
71684000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
74014000
CY2024Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
56759000
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
282773000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30656000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30427000
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
69712000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
70538000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7143000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7144000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22080000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13752000
CY2024Q3 us-gaap Liabilities
Liabilities
258034000
CY2023Q4 us-gaap Liabilities
Liabilities
478648000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55122000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49148000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55094000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49120000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
55000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
49000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1377825000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1059751000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2620000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1165000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-711859000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-599067000
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
28000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
28000
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
132000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
132000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
668509000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
461766000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
926543000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
940414000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
96670000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78048000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
277982000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232346000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22584000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18510000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
65392000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
56684000
CY2024Q3 us-gaap Gross Profit
GrossProfit
74086000
CY2023Q3 us-gaap Gross Profit
GrossProfit
59538000
us-gaap Gross Profit
GrossProfit
212590000
us-gaap Gross Profit
GrossProfit
175662000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64000000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54247000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
192163000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
161034000
CY2024Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
34746000
CY2023Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
33301000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
99898000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
101706000
gkos Research And Development In Process Expense
ResearchAndDevelopmentInProcessExpense
14229000
gkos Research And Development In Process Expense
ResearchAndDevelopmentInProcessExpense
3000000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
98746000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
87548000
us-gaap Operating Expenses
OperatingExpenses
306290000
us-gaap Operating Expenses
OperatingExpenses
265740000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24660000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-28010000
us-gaap Operating Income Loss
OperatingIncomeLoss
-93700000
us-gaap Operating Income Loss
OperatingIncomeLoss
-90078000
CY2024Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
2700000
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
2710000
us-gaap Interest And Other Income
InterestAndOtherIncome
8611000
us-gaap Interest And Other Income
InterestAndOtherIncome
6252000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1663000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3398000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
8468000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
10205000
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
18012000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2391000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1709000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-338000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2978000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3428000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2397000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18207000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6931000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21232000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30407000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-111907000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-97009000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
177000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
885000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
873000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-21409000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-30444000
us-gaap Net Income Loss
NetIncomeLoss
-112792000
us-gaap Net Income Loss
NetIncomeLoss
-97882000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.03
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55037000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55037000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48675000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48675000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51804000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51804000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48284000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48284000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-21409000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-30444000
us-gaap Net Income Loss
NetIncomeLoss
-112792000
us-gaap Net Income Loss
NetIncomeLoss
-97882000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-510000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
561000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
478000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
822000
CY2024Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
939000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
590000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
977000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2917000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
429000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1151000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1455000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3739000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20980000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29293000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-111337000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-94143000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
461766000
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13365000
CY2024Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
5000000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11165000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
272000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-40838000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
450730000
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8819000
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
244088000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11313000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
754000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-50545000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
665159000
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9910000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14420000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
429000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-21409000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
668509000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
530005000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1301000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10184000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1650000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-34626000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
508514000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-702000
CY2023Q2 gkos Adjustments To Additional Paid In Capital Value Of Shares Issued For Acquired In Process Research And Development
AdjustmentsToAdditionalPaidInCapitalValueOfSharesIssuedForAcquiredInProcessResearchAndDevelopment
3000000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9873000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
938000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-32812000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
488811000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7657000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10484000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1151000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-30444000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
477659000
us-gaap Profit Loss
ProfitLoss
-112792000
us-gaap Profit Loss
ProfitLoss
-97882000
us-gaap Depreciation
Depreciation
8181000
us-gaap Depreciation
Depreciation
6455000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18729000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18684000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3194000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3218000
gkos Amortization Of Financing Cost
AmortizationOfFinancingCost
662000
gkos Amortization Of Financing Cost
AmortizationOfFinancingCost
1030000
gkos Change In Deferred Income Tax Expense Benefit
ChangeInDeferredIncomeTaxExpenseBenefit
-1000
gkos Change In Deferred Income Tax Expense Benefit
ChangeInDeferredIncomeTaxExpenseBenefit
-15000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-64000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-881000
us-gaap Share Based Compensation
ShareBasedCompensation
36898000
us-gaap Share Based Compensation
ShareBasedCompensation
30541000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-490000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-991000
gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
-3187000
gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
-1041000
gkos Increase Decrease In Others Accrued Liabilities
IncreaseDecreaseInOthersAccruedLiabilities
4894000
gkos Increase Decrease In Others Accrued Liabilities
IncreaseDecreaseInOthersAccruedLiabilities
2231000
gkos In Process Research And Development Acquired Through Issuance Of Stock
InProcessResearchAndDevelopmentAcquiredThroughIssuanceOfStock
5000000
gkos In Process Research And Development Acquired Through Issuance Of Stock
InProcessResearchAndDevelopmentAcquiredThroughIssuanceOfStock
3000000
gkos Non Cash Inducement Expense Related To Exchange Of Convertible Notes
NonCashInducementExpenseRelatedToExchangeOfConvertibleNotes
17412000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16476000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3535000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18161000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2903000
gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-318000
gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-2355000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4406000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6149000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2008000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
244000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-61825000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-47093000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
123091000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
193538000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
166891000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
238735000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4567000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16034000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
38000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
36044000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
27016000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
29509000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6624000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
7416000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
6278000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4833000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4646000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
665000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
517000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31427000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7739000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-93000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
520000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5553000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11818000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99323000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126603000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104876000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114785000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1165000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1218000
gkos Interest Paid Net Convertible Senior Notes
InterestPaidNetConvertibleSeniorNotes
3953000
gkos Interest Paid Net Convertible Senior Notes
InterestPaidNetConvertibleSeniorNotes
3953000
us-gaap Interest Paid Net
InterestPaidNet
3393000
us-gaap Interest Paid Net
InterestPaidNet
3237000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
226676000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
114000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3201000
CY2024Q2 gkos Upfront Payment To Acquire License
UpfrontPaymentToAcquireLicense
2000000.0
CY2024Q2 gkos Upfront Payment To Acquire License Additional Rights
UpfrontPaymentToAcquireLicenseAdditionalRights
500000
CY2024Q2 gkos Upfront Payment To Acquire License
UpfrontPaymentToAcquireLicense
2000000.0
CY2024Q2 gkos Upfront Payment To Acquire License Additional Rights
UpfrontPaymentToAcquireLicenseAdditionalRights
500000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates and assumptions used in the preparation of the accompanying condensed consolidated financial statements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="color:#0000ff;visibility:hidden;">​</span></p>
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100143000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93467000
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
4733000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
5856000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104876000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99323000
CY2024Q3 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
161660000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
749000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
79000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
162330000
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
202271000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
441000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
748000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
201964000
CY2024Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
57627000
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
41051000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1219000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1201000
CY2024Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
56408000
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
39850000
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
26868000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
16699000
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
14836000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
12870000
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
18191000
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
12417000
CY2024Q3 us-gaap Inventory Gross
InventoryGross
59895000
CY2023Q4 us-gaap Inventory Gross
InventoryGross
41986000
CY2024Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
15646000
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
20588000
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1941000
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2365000
CY2024Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
5685000
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
5269000
CY2024Q3 gkos Accrued Sales Rebates Liabilities Current
AccruedSalesRebatesLiabilitiesCurrent
13297000
CY2023Q4 gkos Accrued Sales Rebates Liabilities Current
AccruedSalesRebatesLiabilitiesCurrent
8935000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
24012000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
23417000
CY2024Q3 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
60581000
CY2023Q4 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
60574000
CY2024Q3 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
CY2023Q4 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
gkos Lessee Leasing Arrangements Operating Leases Number Of Most Significant Leases Expiring
LesseeLeasingArrangementsOperatingLeasesNumberOfMostSignificantLeasesExpiring
2
gkos Lessee Leasing Arrangements Operating Leases Number Of Most Significant Leases Expiring
LesseeLeasingArrangementsOperatingLeasesNumberOfMostSignificantLeasesExpiring
2
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1018000
CY2024Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
1306000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4034000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
5340000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4034000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
5500000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4074000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
5665000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4152000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
5835000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4222000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
6010000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
29346000
CY2024Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
90060000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
50880000
CY2024Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
119716000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
18681000
CY2024Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
48919000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
32199000
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
70797000
CY2024Q3 gkos Lessee Operating Lease Option To Extend Value
LesseeOperatingLeaseOptionToExtendValue
23200000
CY2024Q3 gkos Lessee Financing Lease Option To Extend Value
LesseeFinancingLeaseOptionToExtendValue
75800000
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
271490000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
120972000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
150518000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
102244000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
164056000
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
390390000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
120972000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
269418000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
385200000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
102244000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
282956000
CY2024Q3 us-gaap Goodwill
Goodwill
66134000
CY2024Q3 us-gaap Goodwill
Goodwill
66134000
CY2023Q4 us-gaap Goodwill
Goodwill
66134000
CY2023Q4 us-gaap Goodwill
Goodwill
66134000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5970000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
22979000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
23736000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
24312000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
21896000
CY2024Q3 gkos Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
51625000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
150518000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
96670000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78048000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
277982000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232346000
gkos Period For Payment On Invoice Terms
PeriodForPaymentOnInvoiceTerms
P30D
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2024Q3 gkos Accrued Sales Rebates Liabilities Current
AccruedSalesRebatesLiabilitiesCurrent
13300000
CY2023Q4 gkos Accrued Sales Rebates Liabilities Current
AccruedSalesRebatesLiabilitiesCurrent
8900000
CY2023Q4 gkos Accrued Sales Rebates Liabilities Current
AccruedSalesRebatesLiabilitiesCurrent
8935000
gkos Accrued Sales Rebates Liabilities Current Provision
AccruedSalesRebatesLiabilitiesCurrentProvision
9280000
gkos Accrued Sales Rebates Liabilities Current Payments And Credits
AccruedSalesRebatesLiabilitiesCurrentPaymentsAndCredits
4918000
CY2024Q3 gkos Accrued Sales Rebates Liabilities Current
AccruedSalesRebatesLiabilitiesCurrent
13297000
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4356000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8374000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4289000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8376000
CY2024Q4 gkos Debt Instrument Principal Amount Denomination For Conversion Into Common Stock
DebtInstrumentPrincipalAmountDenominationForConversionIntoCommonStock
1000000
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14420000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10484000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36898000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30541000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
83900000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0083
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0079
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900000
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
35300000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
32800000
CY2024Q3 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
4700000
CY2023Q4 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
5900000
gkos Adjustment Percentage Of Letters Of Credit Balance Outstanding
AdjustmentPercentageOfLettersOfCreditBalanceOutstanding
0.20
CY2024Q3 gkos Minimal Amount Of Letters Of Credit Balance Outstanding After Adjustments
MinimalAmountOfLettersOfCreditBalanceOutstandingAfterAdjustments
2000000.0
CY2024Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
14600000
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
11300000
CY2024Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
14800000
CY2023Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
11600000
gkos Number Of Business Activities
NumberOfBusinessActivities
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001558370-24-014295-index-headers.html Edgar Link pending
0001558370-24-014295-index.html Edgar Link pending
0001558370-24-014295.txt Edgar Link pending
0001558370-24-014295-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gkos-20240930.xsd Edgar Link pending
gkos-20240930x10q.htm Edgar Link pending
gkos-20240930xex31d1.htm Edgar Link pending
gkos-20240930xex31d2.htm Edgar Link pending
gkos-20240930xex32d1.htm Edgar Link pending
gkos-20240930xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
gkos-20240930_cal.xml Edgar Link unprocessable
gkos-20240930_def.xml Edgar Link unprocessable
gkos-20240930_lab.xml Edgar Link unprocessable
gkos-20240930_pre.xml Edgar Link unprocessable
gkos-20240930x10q_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending